Hargreaves, S; Lönnroth, K; Nellums, LB; Olaru, ID; Nathavitharana, RR; Norredam, M; Friedland, JS
(2017)
Multidrug-resistant tuberculosis and migration to Europe.
Clin Microbiol Infect, 23 (3).
pp. 141-146.
ISSN 1469-0691
https://doi.org/10.1016/j.cmi.2016.09.009
SGUL Authors: Nellums, Laura Bruff
|
PDF
Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (596kB) | Preview |
Abstract
Multidrug-resistant tuberculosis (MDR-TB) in low-incidence countries in Europe is more prevalent among migrants than the native population. The impact of the recent increase in migration to EU and EEA countries with a low incidence of TB (<20 cases per 100 000) on MDR-TB epidemiology is unclear. This narrative review synthesizes evidence on MDR-TB and migration identified through an expert panel and database search. A significant proportion of MDR-TB cases in migrants result from reactivation of latent infection. Refugees and asylum seekers may have a heightened risk of MDR-TB infection and worse outcomes. Although concerns have been raised around 'health tourists' migrating for MDR-TB treatment, numbers are probably small and data are lacking. Migrants experience significant barriers to testing and treatment for MDR-TB, exacerbated by increasingly restrictive health systems. Screening for latent MDR-TB is highly problematic because current tests cannot distinguish drug-resistant latent infection, and evidence-based guidance for treatment of latent infection in contacts of MDR patients is lacking. Although there is evidence that transmission of TB from migrants to the general population is low-it predominantly occurs within migrant communities-there is a human rights obligation to improve the diagnosis, treatment and prevention of MDR-TB in migrants. Further research is needed into MDR-TB and migration, the impact of screening on detection or prevention, and the potential consequences of failing to treat and prevent MDR-TB among migrants in Europe. An evidence-base is urgently needed to inform guidelines for effective approaches for MDR-TB management in migrant populations in Europe.
Statistics
Actions (login required)
![]() |
Edit Item |